Erbe introduces VIO® 3n & VIO® seal: Tailored electrosurgical generators for high-performance workflows
With the introduction of the VIO® 3n, Erbe Elektromedizin GmbH expands its established VIO® 3 family with a new generation of electrosurgical generators, specifically tailored to different medical specialties and procedural requirements. The portfolio is further enhanced by the VIO® seal, the first VIO® generator fully dedicated to bipolar applications.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425843193/en/
VIO 3n Fire
Five configurations for precise surgical and endoscopic applications
With over 100 years of experience in electrosurgery, Erbe continues to innovate with the introduction of five new VIO® 3n configurations: Fire, Water, Metal, Timber, and Stone. Each configuration is designed to meet the unique demands of different surgical and endoscopic procedures, providing preprogrammed CUT, COAG, and dissection settings that enhance efficiency and reduce complexity. The VIO® 3n features trusted Erbe electrosurgical modes such as endoCUT®, preciseSECT, and pulsedAPC, ensuring reproducible tissue effects across specialties, also introducing our new mode endoCUT® U, developed for “underwater” applications.
Beyond precise tissue effect adjustment, the VIO® 3n prioritizes intuitive usability: its interface with stepGUIDE supports surgical teams with logical menu navigation and real-time notifications, simplifying setup and operation. Additionally, the generator seamlessly integrates with other Erbe units, such as APC 3 and IES 3, as well as Erbe instruments and accessories allowing flexible adaptation to existing workstations.
VIO® seal: The first VIO® generator for bipolar applications
As a specialized solution for bipolar electrosurgical procedures, the VIO® seal is a significant addition to the Erbe portfolio. Designed for use with TriSect rapide®, BiClamp® and standard bipolar instruments, the unit can function as a standalone solution or in combination with the VIO® 3n as well as existing installed bases like the VIO® D and S series. Featuring digital instrument recognition, it aligns perfectly with surgical workflows.
A key feature: when paired with another VIO® generator, the VIO® seal enables simultaneous bipolar activation, expanding the possibilities of surgical procedures.
A future-proof electrosurgical solution built to fit various clinical demands
With the launch of the VIO® 3n and VIO® seal, Erbe takes another step toward becoming a comprehensive solution provider. The combination of tailored configurations, high-performance workflows, and trusted Erbe technology creates a platform designed to meet the specific needs of various medical specialties.
“After more than 100 years of electrosurgery and over 100,000 VIO® electrosurgical generators sold, Erbe is launching the next generation – the VIO® 3n,” explains Dr. Helmut Scherer, Chief Technology Officer of the Erbe Group. “With the VIO® 3n, the successful operating concept of the VIO® 3 is transferred to the next technology generation and made available for various medical disciplines.”
The new systems will be available in the CE market and CE related countries from April 2025.
About Erbe Elektromedizin
Erbe Elektromedizin develops, manufactures, and distributes surgical instruments and devices worldwide, while providing services for professional use of these products in a diverse range of medical disciplines. Surgeons, OR teams and patients around the world rely on Erbe medical technology. The surgical instruments and devices find use in almost all specialist areas. They are based on electrosurgery combined with other Erbe technologies. Hybrid solutions enable us to provide new, innovative applications in medicine.
Fields of activity
- Imaging
- Endoscopy
- Electrosurgery
- Plasma surgery
- Thermofusion
- Hydrosurgery
- Cryo technology
An international network
- 20 international sales and service units
- 5 production sites
- Erbe is active in 110 international markets.
The Erbe workforce
- 2,100 employees worldwide
- Some 1,100 of them in Germany
View source version on businesswire.com: https://www.businesswire.com/news/home/20250425843193/en/
Contacts
Erbe Elektromedizin GmbH
Waldhoernlestrasse 17
72072 Tuebingen
erbe-med.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.erbe-med.co
m%2F&esheet=54239766&newsitemid=20250425843193&lan=en-US&anchor=erbe-med.com&ind
ex=1&md5=388b47eab0c5becafa55f448f8f57000
info@erbe-med.com
David Malecki
Phone +49 7071 755-316
david.malecki@erbe-med.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte to Highlight Early-Stage Oncology Data at American Association for Cancer Research Annual Meeting 202525.4.2025 15:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced that the Company will present new early-stage data from its oncology portfolio at the American Association of Cancer Research (AACR) Annual Meeting 2025 in Chicago, IL, from April 25–30. “At AACR we will be presenting data from early-stage programs across our oncology portfolio, including for patients with myeloproliferative neoplasms, ovarian cancer and other solid tumors,” said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte. “These data will guide our approach as we advance our pipeline and seek to transform the treatment landscape for patients with cancer and myeloproliferative neoplasms.” Abstracts accepted for presentation at AACR include: Mini Symposium INCB177054 INCB177054: A Novel, Potent, Orally Bioavailable DGKα/ζ Dual Inhibitor Enhances T-Cell Function and Demonstrates Potent Antitumor Activity (Session Title: Novel Antitumor Agents. April 28, 4:50 p.m. – 5:05 p.m. ET (3:50 p.m. – 4:05 p.m. CT). Abstract #
SLB Announces First-Quarter 2025 Results; Remains Committed to Return a Minimum of $4 Billion to Shareholders in 202525.4.2025 13:50:00 EEST | Press release
SLB (NYSE: SLB) today announced results for the first-quarter 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423635499/en/ The exterior of the SLB headquarters in Houston, Texas. First-Quarter Results (Stated in millions, except per share amounts) Three Months EndedChange Mar. 31, 2025 Dec. 31, 2024 Mar. 31, 2024 Sequential Year-on-year Revenue $8,490 $9,284 $8,707 -9% -3% Income before taxes - GAAP basis $1,063 $1,387 $1,357 -23% -22% Income before taxes margin - GAAP basis 12.5% 14.9% 15.6% -241 bps -306 bps Net income attributable to SLB - GAAP basis $797 $1,095 $1,068 -27% -25% Diluted EPS - GAAP basis $0.58 $0.77 $0.74 -25% -22% Adjusted EBITDA* $2,020 $2,382 $2,057 -15% -2% Adjusted EBITDA margin* 23.8% 25.7% 23.6% -186 bps 18 bps Pretax segment operating income* $1,556 $1,918 $1,649 -19% -6% Pretax segment operating margin* 18.3% 20.7% 18.9% -232 bps -60 bps Net income attributable to SLB, excluding charges &
Corona, The World’s Most Valuable Beer Brand 1 , Announces Its 100-Year Anniversary with Global Celebration25.4.2025 11:00:00 EEST | Press release
Today, Corona proudly celebrates its 100-year anniversary, a remarkable milestone for the iconic brand that has been synonymous with the beach and enjoyed by consumers worldwide for the past century. Since 1925, Corona has cultivated a deep association with the beach; fully embodying a lifestyle connected to nature and relaxation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425804516/en/ Corona 100 This Is Living Since 1925 In honor of the occasion, Corona invites everyone to live their “beach side” – a.k.a. their best side – at top-tier beach locations across the globe. The Corona 100 platform includes a film highlighting 100 years of beach culture, a definitive list of the top 100 beaches in the world to visit, and a signed multi-year sponsorship of a renowned concert at Copacabana Beach in Rio de Janeiro — all offering people across the globe opportunities to connect with their beach side. “For 100 years, Corona has
Ant Group Unveils New Recruitment Initiative for Top AI Talents, Ramping Up AI Innovation Efforts25.4.2025 10:28:00 EEST | Press release
Ant Group today unveiled Plan A, a new recruitment initiative to attract top artificial intelligence researchers, reinforcing its commitment to accelerating AI research and development under the “AI First” corporate strategy. Operating within the framework of Ant Star—Ant Group’s year-round campus recruitment program—Plan A specifically targets AI talents who are ambitious, adaptable, altruistic, and analytical. Outstanding graduates from universities worldwide with STEM majors are encouraged to apply for Plan A. Relevant fields include computer science, software engineering, artificial intelligence, cybersecurity, information and telecommunication engineering, mathematics, statistics, and other emerging interdisciplinary areas. To better foster the development of technological innovators in this new AI era, Plan A offers candidates comprehensive support and resources, including unrestricted access to AI hardware and tailored career paths that allow for significant research freedom. Ad
Alipay Sees Tap! Users Pass 100 Million, Accelerating Payment and AI Innovations25.4.2025 05:30:00 EEST | Press release
Alipay Tap!, a QR code-based contactless payment and customer engagement solution introduced by Alipay in China in June 2024, reports today it has won over 100 million users within 11 months. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250424690776/en/ FamilyMart leverages Alipay Tap! to simplify payments and membership management. Alipay Tap! further simplifies the payment experience for both consumers and merchants compared to the “scan-and-pay” model ubiquitous in China. Users tap their unlocked phone against a merchant’s terminal or an Alipay Tap! Tag, eliminating the need to open an app, scan a code, or click through multiple screens. Data from early adopters show the solution also allows merchants to integrate customer engagement tools more seamlessly into the one-tap payment experience. FamilyMart, the nation-wide convenience store chain, reports that membership sign-ups at checkout tripled post-integration. Accord
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom